⭐ Top Story

Cannabis Sector Wednesday Midday Brief July 15 2026 Q2 Earnings Final Window and Schedule III DEA Timeline Frame Afternoon Session Outlook
TL;DR: Cannabis equities are holding Wednesday morning gains through the midday session, with the MSOS ETF sustaining its technical advance above key resistance. The afternoon

Cannabis Sector Wednesday Morning Brief July 15 2026 MSOS Technical Breakout Holds as Q2 Earnings Season Enters Final Reporting Phase
TL;DR: The MSOS ETF carried Tuesday’s technical breakout into Wednesday’s premarket session, with sector price action holding above key resistance as Q2 earnings reports from

Cannabis Sector Tuesday Evening Brief July 14 2026 MSOS After-Hours Strength and Q2 Earnings Countdown Frame Wednesday Session Outlook
TL;DR The AdvisorShares Pure US Cannabis ETF (MSOS) closed Tuesday at $4.49 (+0.67%) and pushed to $4.55 in after-hours trading (+1.34%), extending the day’s gains

Tilray Brands TLRY Tuesday July 14 2026 Midday Analysis International Revenue Diversification and US Hemp Gateway Position FY2026 Investment Thesis
TL;DR: Tilray Brands heads into its FY2026 final quarter with a differentiated thesis built on international medical cannabis expansion and a U.S. hemp and CPG

Cannabis Sector Tuesday Morning Brief July 14 2026 MSOS Holds Q2 Earnings Momentum as MSOs Enter Final Catalyst Window
TL;DR: The cannabis sector heads into Tuesday’s session with MSOS maintaining a constructive technical posture above its 50-day moving average, supported by improving market structure

Cannabis Sector Monday Morning Brief July 13 2026 MSOS Opens New Week With Q2 Earnings Catalyst in Sight as Market Momentum Tests Key Resistance
TL;DR: Cannabis equities open the July 13 trading week with MSOS holding multi-month gains after last week’s constructive close, as the sector enters the final
📈 Top Movers

AYR Wellness AYRWF Wednesday July 15 2026 Midday Analysis Florida Market Defense and Northeast Expansion Anchor Q2 Earnings Pre-Report Thesis
TL;DR: AYR Wellness (OTC: AYRWF) enters Wednesday’s afternoon session as a compelling mid-tier MSO setup ahead of its Q2 2026 earnings report. Florida dispensary density

Cresco Labs CRLBF Wednesday July 15 2026 Morning Analysis Illinois Revenue Leadership and Wholesale Distribution Scale Define Mid-Cap MSO Pre-Earnings Thesis
TL;DR: Cresco Labs (CRLBF) enters Wednesday’s session as one of the more underappreciated large-cap MSOs in the current Q2 earnings cycle, with its wholesale distribution

Verano Holdings VRNOF Tuesday July 14 2026 Midday Analysis Florida Market Defense and Illinois Growth Margin Frame Q2 Earnings Setup
TL;DR: Verano Holdings remains one of the most defensively positioned large-cap MSOs heading into Q2 2026, with Florida market consolidation and Illinois retail density providing

Organigram Holdings OGI Tuesday July 14 2026 Morning Analysis BAT Partnership Revenue and International Export Progress Define Canadian LP Investment Thesis
TL;DR: Organigram Holdings (NASDAQ: OGI) enters Tuesday’s session in a technically neutral posture as investors weigh the company’s ongoing international expansion progress against a domestic

Trulieve Cannabis TCNNF Monday July 13 2026 Evening Analysis 52-Week High Test and Intraday Reversal Signal Key Technical Inflection Ahead of August 6 Earnings
TL;DR: Trulieve Cannabis (TCNNF) tested its 52-week high of $13.28 during Monday’s session before reversing lower in afternoon trade, closing in the $11.76–$11.80 range. The

Curaleaf Holdings CURLF Monday July 13 2026 Pre-Earnings Analysis International Revenue Expansion and Domestic Restructuring Frame Large-Cap MSO Investment Thesis
TL;DR: Curaleaf Holdings (CURLF) enters the final weeks before its Q2 2026 earnings report — expected around August 5 — with a restructuring-driven cost narrative
📰 Today's News

Curaleaf Shareholders Approve Delaware Redomicile, Clearing a Key Hurdle Toward U.S. Exchange Uplisting
TL;DR: Curaleaf Holdings shareholders voted on June 22 to approve the company’s continuation as a Delaware corporation, a structural step that repositions the largest U.S.

DEA Judge Finalizes Cannabis Rescheduling Hearing Timeline as MSOS Sector Holds 2026 Highs
TL;DR: A Drug Enforcement Administration administrative law judge formally set the hearing schedule for cannabis rescheduling proceedings today, June 25, signaling that the multi-year regulatory
Cultivation Consolidation Wave: Which Operators Win?
By Sheeba M. | June 16, 2026 Consolidation Wave: Which Operators Win? TL;DR: Oversupply forces consolidation; winners have efficient cultivation tech and scale. The cannabis
Cannabis Stocks Rally on FDA Approval Signals
By Sheeba M. | June 16, 2026 Cannabis Stocks Rally on FDA Approval Signals TL;DR: Federal agencies hint at accelerated CBD approvals, unlocking $2B+ for
SAFE Act Delays Push Federal Legalization Timeline to 2027
By Sheeba M. | June 16, 2026 SAFE Act Delays Push Federal Legalization Timeline to 2027 TL;DR: Congressional delays in the SAFE Act schedule suggest
State Cannabis Sales Climb to Record $17.5B in 2026 H1
By Sheeba M. | June 16, 2026 State Cannabis Sales Climb to Record $17.5B in 2026 H1 TL;DR: Legal cannabis sales reached $17.5 billion in